Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy ...

The Food and Drug Administration wants bulk production of the copycats to stop—starting Wednesday for pharmacy-prepared versions of Zepbound and later in the spring for knockoffs of Ozempic and ...

Money may not grow on trees — but Ozempic soon might. A team of enterprising University of Ottawa undergraduate students have ...

Victor Boddy wasn’t expecting to reinvent pharmaceutical manufacturing before graduation. But as drug shortages made ...

Up in Canada, students have developed an incredible new way to synthesize drugs on plants — and they're using Ozempic as their ... Nicotiana benthamiana into a pharmaceutical factory for the ...

As medical professionals and researchers continue searching for effective treatments, a drug called Ozempic (semaglutide) has emerged as a potential therapy. Originally approved for type 2 ...

I Prescribe Ozempic. Here's What RFK Jr. Is Getting ... generic or compounded versions could be limited by regulations and pharmaceutical companies’ influence. That’s why it’s so important ...

With a FDA deadline set for March 26 to stop compounding versions of Zepbound, followed by restrictions on compounded Ozempic and Wegovy set for later this spring, the agency is meeting resistance ...